CAN NRF2 MODULATION BE A NOVEL THERAPEUTIC APPROACH IN ACUTE MYELOBLASTIC LEUKEMIA?
EHA Library, Ana Bela Sarmento-Ribeiro, 297719
IDH2 MUTATIONS COULD BE AN USEFUL MRD MARKER IN ACUTE MYELOID LEUKEMIA.
EHA Library, Sara Galimberti, 297720
HIGHLY EXPRESSED RIBOSOMAL PROTEIN L34 PREDICTS POOR PROGNOSIS IN ACUTE MYELOID LEUKEMIA AND COULD BE A POTENTIAL THERAPY TARGET
EHA Library, Liang Wang, 297721
EFFECTS OF E35-INDUCED AUTOPHAGY AND APOPTOSIS IN ACUTE MYELOID LEUKEMIA HL-60 AND KASUMI CELLS
EHA Library, Li Zhang, 297722
TRANSCRIPTOME ANALYSIS OF PEDIATRIC ACUTE MYELOID LEUKEMIA WITH COMPLEX KARYOTYPE
EHA Library, Lilit Ghukasyan, 297723
HIGH LEVELS OF LEUKEMIC STEM CELLS CORRELATE WITH UNFAVORABLE PROGNOSIS IN A BRAZILIAN COHORT OF ACUTE MYELOID LEUKEMIA WITH NORMAL KARYOTYPE.
EHA Library, Lorena Figueiredo-Pontes, 297724
EXPERIMENTAL APPROACH TO PERSONALIZED TREATMENT OF PATIENTS WITH ACUTE MYELOID LEUKEMIA BASED ON A CHEMOSENSITIVITY TEST
EHA Library, Hanna Trubkina, 297725
DEFICIENT REGULATORY INNATE LYMPHOID CELLS AND DIFFERENTIAL EXPRESSION OF MIRNAS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AND APLASTIC ANEMIA
EHA Library, Jifeng Yu, 297726
AN IMMUNE RISK SCORE PREDICTS SURVIVAL OF PERSONS WITH ACUTE MYELOID LEUKEMIA RECEIVING CHEMOTHERAPY
EHA Library, Yang Liang, 297727
RARE TRANSLOCATION IN BONE MARROW CELLS OF PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)
EHA Library, Sarka Ransdorfova, 297728
ABNORMAL MITOCHONDRIAL DYNAMICS IN RELAPSE/REFRACTORY AML:IMBALANCE OF MITOCHONDRIAL FUSION AND DIVISION
EHA Library, Zhilong Xu, 297729
IDENTIFICATION OF NOVEL RELAPSE-ASSOCIATED GENETIC MARKERS OF ACUTE MYELOID LEUKEMIA BY WHOLE-EXOME SEQUENCING AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Mengge Gao, 297730
CYTOGENETICS' IMPACT ON THE PROGNOSIS OF PEDIATRIC ACUTE MYELOID LEUKEMIA AMONG DIFFERENT AGE GROUPS
EHA Library, Georgia Avgerinou, 297731
CLINICAL SIGNIFICANCE OF GATA1, GATA2 AND TAL1 EXPRESSION SIGNATURES IN ACUTE MYELOID LEUKEMIA.
EHA Library, Elmira Vagapova, 297732
ACUTE MYELOID LEUKEMIA WITH ETV6 GENE REARRANGEMENTS
EHA Library, Elena Zerkalenkova, 297733
MICRORNA EXPRESSION PROFILES HAVE SPECIFIC POINTS IN SUBGROUPS OF ACUTE PROMYELOCYTIC LEUKEMIA
EHA Library, Y.A. Veryaskina, 297734
CLINICAL IMPACT OF PERCENTAGE OF NATURAL KILLER CELLS AND NATURAL KILLER LIKE T-CELL POPULATION IN ACUTE MYELOID LEUKEMIA.
EHA Library, Esraa Jamal, 297735
NEXT GENERATION SEQUENCING PROFILE BY ILLUMINA TRUSIGHT MYELOID SEQUENCING PANEL (TSM). FREQUENCIES AND OUTCOMES IN A COHORT OF PERUVIAN PATIENTS WITH MYELOID MALIGNANCIES
EHA Library, Antonio Carrasco-Yalan, 297736
IMPACT OF FLT3-ITD GENE MUTATIONS IN ACUTE PROMYELOCYTIC LEUKEMIA IN MALAYSIA
EHA Library, Siew Lian Chong, 297737
DUPLICATION SIZE AND ALLELIC BURDEN FOR FLT3 ITD MUTATIONS IN ACUTE MYELOID LEUKEMIA- CLINICAL AND PARACLINICAL CORRELATIONS
EHA Library, Simona-Maria Galdean, 297738
ARCHIVING OF SOMATIC NOVEL MUTATIONS USING WHOLE-EXOME SEQUENCING IN PAKISTANI MYELOID LEUKEMIC PATIENTS
EHA Library, Abdul Rehman Shaikh, 297739
GLYPICAN-3 INFLUENCES THE PROCOAGULANT ACTIVITY OF LEUKEMIC CELLS BY REGULATING TISSUE FACTOR
EHA Library, Xueyan Cui, 297740
MYELOID SARCOMA WITH MEGAKARYOBLASTIC DIFFERENTIATION:A CASE REPORT
EHA Library, Xiaona Zuo, 297741
SYNDECAN-1 AS A PROGNOSTIC BIOMARKER IN ACUTE MYELOID LEUKEMIA
EHA Library, Reham Alghandour, 297742
CUP-LIKE BLASTS IN ACUTE MYELOID LEUKEMIA WITH FLT3 AND NPM1 MUTATIONS
EHA Library, Christopher Saunders, 297744
THE IMPORTANCE OF MONITORING ARSENIC METHYLATION METABOLISM IN APL PATIENTS WITH THE TREATMENT OF ARSENIC TRIOXIDE
EHA Library, Hongming Zhu, 297745
THERAPY-RELATED AML (T-AML) IS A HETEROGENEOUS DISEASE: BIOLOGICAL AND CLINICAL DIFFERENCES BETWEEN CASES RELATED TO BREAST CANCER AND TO LYMPHOMA TREATMENT
EHA Library, Giambattista Bertani, 297746
TREATMENT PATTERNS AND OUTCOMES OF NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS RECEIVING VENETOCLAX COMBINATIONS VS OTHER THERAPIES: RESULTS FROM THE AML REAL WORLD EVIDENCE (ARC) INITIATIVE
EHA Library, Chetasi Talati, 297747
PATIENT EXPERIENCES WITH LIPOSOMAL DAUNORUBICIN AND CYTARABINE (CPX-351) VS CONVENTIONAL INDUCTION REGIMENS: AN ANALYSIS OF PATIENT-REPORTED OUTCOMES DATA FROM A PROSPECTIVE TRIAL
EHA Library, Thomas W. LeBlanc, 297748
PROGRESSIVE HYPERLEUKOCYTOSIS ASSOCIATES WITH DIFFERENTIAL SYNDROME IN ACUTE PROMYELOCYTIC LEUKEMIA PATIENTS TREATED WITH ALL-TRANS RETINOIC ACID AND ARSENIC TRIOXIDE
EHA Library, Qunfang Li, 297749
LIPOSOMAL ANNAMYCIN - A NEXT GENERATION ANTHRACYCLINE OVERCOMING MDR WITH NO CARDIAC TOXICITY
EHA Library, Robert Shepard, 297750
PRECISION MEDICINE IN HEMATOLOGY-ONCOLOGY: CDA AS A PREDICTIVE MARKER FOR CYTARABINE EXPOSURE IN AML PATIENTS
EHA Library, Melanie Donnette, 297751
PROGNOSTIC SIGNIFICANCE OF THE IMMUNE CHECKPOINT TIM-3 GENE EXPRESSION IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS AND ITS CORRELATION TO EXTRAMEDULLARY DISEASE
EHA Library, Nermeen Adel, 297752
ARTIFICIAL INTELLIGENCE TOOL BASED CELL POPULATION DATA DRIVEN APPROACH FOR EARLY PREDICTION OF ACUTE PROMYELOCYTIC LEUKEMIA
EHA Library, Rana Zeeshan Haider, 297753
DIABETES INSIPIDUS AS A CLINICAL MANIFESTATION IN AML WITH INV(3)(Q21.3Q26.2) AND MONOSOMY 7: IS IT COINCIDENTAL?
EHA Library, Olga Salamero, 297754
EARLY MORTALITY IN PATIENTS WITH ACUTE MIELOID LEUKEMIA WITH HYPERLEUCOCITOSIS IN ONE SPANISH CENTRE
EHA Library, Verónica Campuzano, 297755
HIGH-DOSE CYTARABINE IN COMBINATION WITH ANTHRACYCLINES AS INDUCTION TREATMENT IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
EHA Library, Ángela Gil, 297756
ARSENIC TRIOXIDE AND ALL-TRANS RETINOIC ACID COMBINATION IN PEDIATRIC ACUTE PROMYELOCYTIC LEUKEMIA: RETROSPECTIVE MONOCENTRIC EXPERIENCE
EHA Library, Giovanna Giagnuolo, 297757
PATIENT CHARACTERISTICS AND OUTCOMES IN ADOLESCENTS AND YOUNG ADULTS (AYA) WITH ACUTE MYELOID LEUKEMIA (AML)
EHA Library, Elissavet Chrysavgi Lalagianni, 297758
THE CLINICAL SIGNIFICANCE OF CD69 DETECTION IN MINIMAL RESISUAL DISEASE OF PATIENS WITH ACUTE MYELOID LEUKEMIA
EHA Library, Hui Wang, 297759
OUTCOME OF CBF LEUKEMIA PATIENTS ACCORDING TO THEIR GENETIC SUBTYPE: A COMPARATIVE ANALYSIS
EHA Library, Apostolia Papalexandri, 297760
TREATMENT OUTCOMES OF SECONDARY ACUTE MYELOID LEUKEMIA WITH CPX-351 (LIPOSOMAL DAUNORUBICIN:CYTARABINE) – A SINGLE INSTITUTION OUTCOMES ANALYSIS & EXPERIENCE
EHA Library, Anish Konde, 297761
ROLE OF GPX3 EXPRESSION LEVEL STATUS IN DIAGNOSIS AND TREATMENT OF EGYPTIAN AML PATIENTS
EHA Library, Yasmine Shaaban, 297762
HYPOMETHYLATING AGENTS OR INTENSIVE CHEMOTHERAPY IN ELDERLY AML PATIENTS: EVALUATION OF THE CLINICAL OUTCOME FROM TWO TERTIARY CENTERS OF NORTHERN ITALY.
EHA Library, Federica Lessi, 297763
HYPOMETHYLATING AGENTS OR INTENSIVE CHEMOTHERAPY FOR ELDERLY AML PATIENTS: INFLUENCING FACTORS ON THERAPY SELECTION AND THEIR IMPACT ON THE OUTCOME IN THE ARGENTINE REAL-WORLD
EHA Library, Maria Jose Mela Osorio, 297764
ACUTE PROMYELOCYTIC LEUKEMIA: IS AGE A MAJOR DETERMINANT OF OUTCOME?
EHA Library, Carolina Afonso, 297765
VENETOCLAX PLUS HMAS FOR ACUTE MYELOID LEUKEMIA (AML) IS AN EFFECTIVE AND MANAGEABLE REGIMEN IN THE OUTPATIENT SETTING: A REAL-LIFE EXPERIENCE.
EHA Library, Jacopo Nanni, 297766
INCIDENCE AND CHARACTERISTICS OF DIFFERENTIATION SYNDROME (DS) IN ACUTE PROMYELOCYTIC LEUKEMIA (APML) – A SINGLE CENTER RETROSPECTIVE OBSERVATIONAL STUDY
EHA Library, Swaratika Majumdar, 297767
REPORTING OF A MULTIVARIABLE PREDICTION MODEL FOR INDIVIDUAL PROGNOSIS OF CHINESE FLT3-ITD-POSITIVE ACUTE MYELOID LEUKEMIA
EHA Library, Yi Zhang, 297768
HIGH LEVELS OF CXCR2 EXPRESSION PREDICT POOR PROGNOSIS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
EHA Library, Xian Li, 297769
PROGNOSTIC RELEVANCE OF CD25 EXPRESSION IN ACUTE MYELOID LEUKEMIA
EHA Library, Fátima Mirás Calvo, 297770
USE OF GEMTUZUMAB OZOGAMICIN IN RELAPS REFRACTORY ACUTE MYELOBLASTIC LEUKEMIA: MULTI-CENTER RETROSPECTİVE STUDY
EHA Library, irfan yavaşoğlu, 297771
PRIOR CLL-1 CAR-T CELL THERAPY SET UP AN EXCELLENT BASE OF COMING HEMATOPOIETIC STEM CELL TRANSPLANTATION IN REFRACTORY/RECURRENT ACUTE MYELOID LEUKEMIA: A CASE REPORT
EHA Library, Chaoke Pu, 297772
PREDICTORS OF EARLY DEATH IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
EHA Library, Nikica Sabljic, 297773
SURVIVAL ANALYSIS OF ADULT PATIENTS (PTS) WITH THERAPY-RELATED ACUTE MYELOID LEUKEMIA (T-AML): A SINGLE CANCER CENTER EXPERIENCE.
EHA Library, BELHABRI AMINE, 297774
CD200 EXPRESSION, THE ADVERSE PROGNOSTIC FACTOR IN ACUTE MYELOID LEUKEMIA AND OTHER HEMATOLOGIC MALIGNANCIES: A SYSTEMATIC REVIEW AND META-ANALYSIS
EHA Library, Thanawat Rattanathammethee, 297775
THE YIELD AND SAFETY OF SKIN BIOPSIES IN ACUTE MYELOID LEUKEMIA PATIENTS DURING INTENSIVE CHEMOTHERAPY TREATMENT
EHA Library, Tamar Berger, 297776
INFECTIONS AND INFECTION RELATED MORTALITY IN ADOLESCENT AND ADULTS WITH ACUTE MYELOID LEUKEMIA TREATED IN A TERTIARY CARE CENTRE- A RETROSPECTIVE ANALYSIS
EHA Library, Dr. Karthik Rengaraj, 297777
AGILE: PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF IVOSIDENIB IN COMBINATION WITH AZACITIDINE IN ADULTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA AND AN IDH1 MUTATION
EHA Library, Pau Montesinos, 297778
PROGNOSTIC SIGNIFICANCE OF DNMT3A GENE EXPRESSION AND REACTIVE NITROGEN SPECIES IN NEWLY DIAGNOSED DE-NOVO ADULT ACUTE MYELOID LEUKEMIA PATIENTS
EHA Library, Walaa Elsalakawy, 297779
E CADHERIN EXPRESSION IN BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASMS : AN UNRECOGNISED FINDING AND POTENTIAL DIAGNOSTIC PITFALL
EHA Library, Richard Chasty, 297780
UNUSUAL PRESENTATION OF ACUTE MYELOID LEUKEMIA WITH CUP-LIKE BLASTS AND RUNX1/RUNX1T1 REARRANGEMENTS – A SINGLE INSTITUTION SERIES
EHA Library, Milan Jagurinoski, 297781
OVERALL SURVIVAL AND TREATMENT RESPONSE IN ADULTS PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA
EHA Library, Claudia Sossa-Melo, 297782
NEXT-GENERATION SEQUENCING ANALYSIS IN PATIENTS WITH MYELODISPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA WITH ACTIVE DISEASE AT ALLOGENEIC STEM CELL TRANSPLANTATION
EHA Library, Alejandro Avendaño Pita, 297783
OUTCOMES OF ALLOGENEIC STEM CELL TRANSPLANTATION AMONG CHILDREN WITH ACUTE MYELOID LEUKEMIA
EHA Library, Rym El Fatmi, 297784
PRESENCE OF MINIMAL RESIDUAL DISEASE (MRD) BY FLOW CYTOMETRY IN ACUTE MYELOID LEUKEMIA PATIENTS MAY IDENTIFY PATIENTS AT INCREASED RISK OF RELAPSE: A STEP TO THE FUTURE IS COMING SOON.
EHA Library, Walaa Elsalakawy, 297785
FRONTLINE TREATMENT WITH VENETOCLAX, POSACONAZOLE, AND STANDARD DOSE CYTARABINE OR AZACITIDINE FOLLOWED BY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
EHA Library, Tran-Der Tan, 297786
RETROSPECTIVE STUDY OF THE USE OF VENETOCLAX IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA
EHA Library, JORGE LABRADOR GOMEZ, 297787
A REAL LIFE TURKISH EXPERIENCE OF VENETOCLAX TREATMENT IN HIGH RISK MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA
EHA Library, Omur Gokmen Sevindik, 297788
CORE-BINDING FACTOR IN CHILDHOOD ACUTE MYELOID LEUKEMIA
EHA Library, Youssra Fakhfakh, 297789
REDUCTIVE REGULATION OF BECN1 GENE IN ADULT EGYPTIAN PATIENTS WITH DO NOVO AML
EHA Library, Walaa Elsalakawy, 297790
THE STIMULUS CLINICAL TRIAL PROGRAM: EVALUATING COMBINATION THERAPY WITH MBG453 IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROME (HR-MDS) OR ACUTE MYELOID LEUKEMIA (AML)
EHA Library, Amer M. Zeidan, 297791
HIGH-RISK AML: ONLINE TEAM-BASED EDUCATION SIGNIFICANTLY IMPROVES KNOWLEDGE AND SKILLS
EHA Library, Lauren Willis, 297792
PRIMARY CENTRAL NERVOUS SYSTEM MYELOID SARCOMA EVOLVING FROM A MYELOID NEOPLASM WITH EOSINOPHILIA ASSOCIATED WITH FIP1L1‐PDGFRA
EHA Library, Julian Matias Freue, 297793
CONSOLIDATION TREATMENT OF ACUTE MYELOID LEUKEMIA IN THE WEST OF ALGERIA
EHA Library, Mohamed Aberkane, 297794
STUDY OF TREATMENT IMPACT ON PATIENTS WITH ATLS, SIRS AND MOD ASSOCIATED WITH AGGRESSIVE HEMATOLOGICAL MALIGNANCIES – THE EXPERIENCE OF A ROMANIAN CENTER
EHA Library, Mihaela Andreescu, 297795
CUTANEOUS ULCERATION DURING TREATMENT WITH ALL TRANS RETINOIC ACID OF ACUTE PROMYELOCYTIC LEUKEMIA
EHA Library, Olfa Kassar, 297796
SURVIVAL ANALYSIS OF CHILDHOOD ACUTE MYELOBLASTIC LEUKEMIA: DIAGNOSTIC LYMPHOPENIA AS AN UNFAVORABLE PROGNOSTIC FACTOR
EHA Library, Bambang Ardianto, 297797
ROLE OF PLASMACYTOID DENDRITIC CELL INFILTRATION IN ACUTE MYELOID LEUKEMIA
EHA Library, John Zhong, 297798
FLT3-MUTATED AML: CASE-BASED EDUCATION IMPROVES PHYSICIAN KNOWLEDGE AND SKILLS
EHA Library, Lauren Willis, 297799
INCREASED PSMD10 EXPRESSION IN BONE MARROW OF PATIENTS WITH ACUTE MYELOID LEUKEMIA
EHA Library, Yukie Izuka, 297800
EPIDEMIOLOGICAL DATA FOR ACUTE MYELOID LEUKEMIA IN ALBANIA FROM 2007-2018.
EHA Library, Polikron Pulluqi, 297801
OUTCOMES AND TOXICITY ASSESSMENT OF INDUCTION 7+3 (IDARUBICIN) IN COMBINATION WITH MIDOSTAURIN IN TREATMENT-NAÏVE, FLT3-MUTATED ELDERLY AML PATIENTS.
EHA Library, Ankita Tandon, 297802
HOW TO BETTER DEFINE EVENT-FREE SURVIVAL IN A CLINICAL TRIAL WITH AML PATIENTS NOT TOLERATING INTENSIVE CHEMOTHERAPY?
EHA Library, Severine Peyrard, 297803
VENETOCLAX PLUS 5AZACYTIDINE FAILURE TREATMENT IN AN IDH1 AND DNMT3A MUTATED REFRACTORY AML PATIENT WITH LEUKEMIA CUTIS
EHA Library, Jian Huang, 297804
REAL WORLD OUTCOMES OF 7+3 INDUCTION CHEMOTHERAPY FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA IN MOROCCO (A SINGLE CENTER REPORT)
EHA Library, Mahtat EL MEHDI, 297805
AZACITIDINE AS MAINTENANCE AFTER STANDARD THERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA, A MEXICAN CENTER EXPERIENCE.
EHA Library, José Antonio Delapeña-Celaya, 297806
MASSIVE BONE MARROW INFILTRATION BY AGGRESSIVE NEUROENDOCRINE TUMOR MIMICKING ACUTE MYELOID LEUKEMIA
EHA Library, Rafael Rios-Tamayo, 297807
MAINTENANCE THERAPY WITH DECITABINE IN FRAIL PATIENTS WITH ACUTE MYELOBLASTIC LEUKEMIA. EXPERIENCE OF A SINGLE CENTRE.
EHA Library, Alfredo Gagliardi, 297808
PHASE 1B STUDY OF CPX-351 LOWER-INTENSITY THERAPY PLUS VENETOCLAX AS FIRST-LINE TREATMENT FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA WHO ARE UNFIT FOR INTENSIVE CHEMOTHERAPY
EHA Library, Tara L. Lin, 297809
THE DIFFERENTIAL SYNDROME IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA: A TUNISIAN SINGLE CENTRE EXPERIENCE
EHA Library, kasser olfa, 297810
CLINICAL SIGNIFICANCE OF NPM1 MUTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA IN A REAL-LIFE SETTING
EHA Library, Mirta Mikulic, 297811
DOWN REGULATION OF LEF-1 EXPRESSION IN CASES OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH ATYPICAL IMMUNOPHENOTYPE (ATYPICAL CLL)
EHA Library, Dina Sameh Soliman, 297812
EXPRESSION PATTERN AND PROGNOSTIC SIGNIFICANCE OF BCL11A GENE IN CHRONIC LYMPHOCYTIC LEUKEMIA
EHA Library, Teodora Karan-Đurašević, 297813
GENE MUTATIONS ANALYSIS AND NEW INSIGHTS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): PRELIMINARY RESULTS FROM A CLINICAL RESEARCH PROJECT BASED ON NEXT GENERATION SEQUENCING (NGS)
EHA Library, Roberta Murru, 297814
NOVEL THIENOPYRIDINE DERIVATIVES INDUCE TUBULIN DISRUPTION, CAUSE CELL CYCLE ARREST AND INHIBIT ACTIVATION OF PLCG2 IN MALIGNANT B-CELLS
EHA Library, Christopher Broughton, 297815
CIRCULATING MICROENVIRONMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA: A KEY ROLE OF MONOCYTES
EHA Library, Eva Kriegová, 297816
REDOX BALANCE AS THE CRITERION FOR PERSONIFIED REGISTRATION OF RESPONSE FROM B-CLL CELLS TO THERAPY
EHA Library, Yuliya Harmaza, 297817
LEF-1 GENETIC POLYMORPHISMS IN ASSOCIATION WITH CHRONIC LYMPHOCYTIC LEUKEMIA FORMATION AND SURVIVAL
EHA Library, Enas Dawoud, 297818
GENETIC LESIONS IN RUSSIAN CLL#1 SUBSET PATIENTS.
EHA Library, Bella Biderman, 297819

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings